Showing results (1-10 of 283) with videos related to
Sort By:
Pageof 29
The Journal of Clinical Psychiatry|March 30, 2000
Review of incidence studies of tardive dyskinesia associated with typical antipsychoticsW M GlazerThe Journal of Clinical Psychiatry|March 30, 2000
Expected incidence of tardive dyskinesia associated with atypical antipsychoticsW M GlazerThe Journal of Clinical Psychiatry|May 26, 1999
Does loxapine have "atypical" properties? Clinical evidenceW M GlazerEmployee Benefits Journal|June 1, 1993
Psychiatric treatment programs: the continuous services modelW M GlazerThe Journal of Clinical Psychiatry|January 1, 1997
Olanzapine and the new generation of antipsychotic agents: patterns of useW M GlazerThe Journal of Clinical Psychiatry|March 21, 2000
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicalityW M GlazerEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1996
The impact of managed care systems on relapse prevention and quality of life for patients with schizophreniaW M GlazerThe Journal of Clinical Psychiatry|December 10, 1998
Formulary decisions and health economicsW M GlazerSchizophrenia Research|November 1, 1988
Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesiaW M GlazerPageof 29